Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation: Arrhythmia and Electrophysiology
Search: search_blue_button Advanced Search
Published Online
on December 7, 2008

Circulation: Arrhythmia and Electrophysiology. 2008
Published online before print December 7, 2008, doi: 10.1161/CIRCEP.108.818427
A more recent version of this article appeared on February 1, 2009
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
2/1/50    most recent
CIRCEP.108.818427v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Valderrabano, M.
Right arrow Articles by Khoury, D. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Valderrabano, M.
Right arrow Articles by Khoury, D. S.
Related Collections
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Catheter-based coronary and valvular interventions: other
Right arrowRelated Article

Original Article

Retrograde ethanol infusion in the vein of Marshall: Regional left atrial ablation, vagal denervation and feasibility in humans

Miguel Valderrabano1; Harvey R. Chen; Jasvinder S. Sidhu; Liyun Rao; Yuesheng Ling and Dirar S. Khoury

The Methodist Hospital Research Institute and The Methodist Hospital, Houston, TX

1 E-mail: mvalderrabano{at}tmhs.org

Background—The vein of Marshall (VOM) is an attractive target during ablation of atrial fibrillation due to its autonomic innervation, its location anterior to the left pulmonary veins and drainage in the coronary sinus.

Methods and Results—We studied 17 dogs. A coronary sinus venogram showed a VOM in 13, which was successfully cannulated with an angioplasty wire and balloon. In 5 dogs, electroanatomical maps of the left atrium were performed at baseline and after ethanol infusion in the VOM, which demonstrated a new crescent-shaped scar, extending from the annular left atrium towards the posterior wall and left pulmonary veins. In 4 other dogs, effective refractory periods (ERP) were measured at 3 sites in the left atrium, before and after high-frequency bilateral vagal stimulation. The ERP decreased from 113.6±35.0 ms to 82.2±25.4 ms (p<0.05) after vagal stimulation. After VOM ethanol infusion, vagally-mediated ERP decrease was eliminated (from 108.6±24.1 ms to 96.4±16.9ms, p=NS). The abolition of vagal effects was limited to sites near the VOM (ERP: 104±14 ms, vs 98.6±12.2 ms post vagal stimulation, p=ns), as opposed to sites remote to VOM (ERP: 107.2±14.9 ms, vs 78.6±14.7ms post vagal stimulation, p<0.05). To test feasibility in humans, 6 patients undergoing pulmonary vein antral isolation had successful VOM cannulation and ethanol infusion: left atrial voltage maps demonstrated new scar involving the infero-posterior left atrial wall extending towards the left pulmonary veins.

Conclusions—Ethanol infusion in then VOM achieves significant left atrial tissue ablation, abolishes local vagal responses and is feasible in humans.

Key Words: ablation • alcohol • atrium • catheter ablation • catheterization


Related Article

Retrograde Ethanol Infusion in the Vein of Marshall: Regional Left Atrial Ablation, Vagal Denervation, and Feasibility in Humans
Miguel Valderrábano, Harvey R. Chen, Jasvinder Sidhu, Liyun Rao, Yuesheng Ling, and Dirar S. Khoury
Circ Arrhythm Electrophysiol 2009 2: 50-56. [Abstract] [Full Text] [PDF]